File Download
Patent History
- ApplicationUS 11/411745 2006-04-25
- GrantedUS 20070203062 2007-08-30
Patent Family
- JP 2008539257 (A) 2008-11-13
- AU 2006241123 (A1) 2006-11-02
- CA 2609656 (A1) 2006-11-02
- CN 101267831 (A) 2008-09-17
- DK 1879606 (T3) 2013-09-23
- EP 1879606 (A1) 2008-01-23
- EP 2283851 (A2) 2011-02-16
- ES 2427565 (T3) 2013-10-31
- HK 1112847 (A1) 2014-03-14
- J P5204646 (B2) 2013-06-05
- JP 2011168623 (A) 2011-09-01
- J P5629241 (B2) 2014-11-19
- JP 2014221830 (A) 2014-11-27
- KR 20080007380 (A) 2008-01-18
- KR 20100102750 (A) 2010-09-24
- US 2009111734 (A1) 2009-04-30
- WO 2006116524 (A1) 2006-11-02
Supplementary
-
Citations:
- Appears in Collections:
granted patent: Compositions and methods for promoting hemostasis and other physiological activities
Title | Compositions and methods for promoting hemostasis and other physiological activities |
---|---|
Granted Patent | US 20070203062 |
Granted Date | 2007-08-30 |
Priority Date | 2006-01-13 US 11/758827P 2005-04-25 US 11/674612P 2006-04-25 US 11/411745 |
Inventors | |
Issue Date | 2007 |
Citation | US Patent US 20070203062. Washington, DC: US Patent and Trademark Office (USPTO), 2007 How to Cite? |
Abstract | Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described. |
Persistent Identifier | http://hdl.handle.net/10722/210493 |
References |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2015-06-17T07:02:52Z | - |
dc.date.available | 2015-06-17T07:02:52Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | US Patent US 20070203062. Washington, DC: US Patent and Trademark Office (USPTO), 2007 | - |
dc.identifier.uri | http://hdl.handle.net/10722/210493 | - |
dc.description.abstract | Compositions that include nanoscale structured materials or precursors thereof (e.g., self-assembling peptides) are described. The compositions can include other substances (e.g., a vasoconstrictor). Also described are methods for using the compositions to promote hemostasis, to protect the skin or wounds from contamination, to decontaminate a site upon removal of previously applied compositions that provided a protective coating, and to inhibit the movement of bodily substances other than blood. The compositions are also useful in isolating tissue, removing tissue, preserving tissue (for, e.g., subsequent transplantation or reattachment), and as bulking, stabilizing or hydrating agents. Medical devices that include the compositions (e.g., a stent or catheter), bandages or other wound dressings, sutures, and kits that include the compositions are also described. | - |
dc.relation.isreferencedby | US 2011196326 (A1) 2011-08-11 | - |
dc.relation.isreferencedby | US 2010184950 (A1) 2010-07-22 | - |
dc.relation.isreferencedby | A U2009232000 (B2) 2014-12-11 | - |
dc.relation.isreferencedby | AU 2009232000 (A1) 2009-10-08 | - |
dc.relation.isreferencedby | US 2011054326 (A1) 2011-03-03 | - |
dc.relation.isreferencedby | U S8546338 (B2) 2013-10-01 | - |
dc.relation.isreferencedby | U S7696309 (B2) 2010-04-13 | - |
dc.relation.isreferencedby | US 2012014925 (A1) 2012-01-19 | - |
dc.relation.isreferencedby | U S8741833 (B2) 2014-06-03 | - |
dc.relation.isreferencedby | U S8153582 (B2) 2012-04-10 | - |
dc.relation.isreferencedby | US 2012148674 (A1) 2012-06-14 | - |
dc.relation.isreferencedby | WO 2013025685 (A1) 2013-02-21 | - |
dc.relation.isreferencedby | US 2015056263 (A1) 2015-02-26 | - |
dc.relation.isreferencedby | US 2008095758 (A1) 2008-04-24 | - |
dc.relation.isreferencedby | U S7906478 (B2) 2011-03-15 | - |
dc.relation.isreferencedby | U S8828358 (B2) 2014-09-09 | - |
dc.relation.isreferencedby | U S8852558 (B2) 2014-10-07 | - |
dc.relation.isreferencedby | US 2009232877 (A1) 2009-09-17 | - |
dc.relation.isreferencedby | WO 2009123903 (A1) 2009-10-08 | - |
dc.relation.isreferencedby | U S7999067 (B2) 2011-08-16 | - |
dc.relation.isreferencedby | US 2009036851 (A1) 2009-02-05 | - |
dc.relation.isreferencedby | US 2009169521 (A1) 2009-07-02 | - |
dc.relation.isreferencedby | US 2009232876 (A1) 2009-09-17 | - |
dc.title | Compositions and methods for promoting hemostasis and other physiological activities | - |
dc.type | Patent | - |
dc.identifier.authority | TAY DAVID=rp00336 | - |
dc.identifier.authority | ELLIS-BEHNKE RUTLEDGE=rp00252 | - |
dc.identifier.authority | SO KWOK-FAI=rp00329 | - |
dc.identifier.authority | LIANG YU-XIANG=rp00510 | - |
dc.description.nature | published_or_final_version | - |
dc.contributor.inventor | ELLIS-BEHNKE RUTLEDGE | - |
dc.contributor.inventor | LIANG YU-XIANG | - |
dc.contributor.inventor | SCHNEIDER GERALD | - |
dc.contributor.inventor | SO KWOK-FAI | - |
dc.contributor.inventor | TAY DAVID | - |
dc.contributor.inventor | ZHANG SHUGUANG | - |
patents.identifier.application | US 11/411745 | - |
patents.identifier.granted | US 20070203062 | - |
patents.description.country | United States of America | - |
patents.date.granted | 2007-08-30 | - |
dc.relation.references | U S8022178 (B2) 2011-09-20 | - |
dc.relation.references | US 2009162437 (A1) 2009-06-25 | - |
patents.identifier.hkutechid | Anat-2005-00186-1 | - |
patents.date.application | 2006-04-25 | - |
patents.date.priority | 2006-01-13 US 11/758827P | - |
patents.date.priority | 2005-04-25 US 11/674612P | - |
patents.date.priority | 2006-04-25 US 11/411745 | - |
patents.description.cc | us | - |
patents.relation.family | JP 2008539257 (A) 2008-11-13 | - |
patents.relation.family | AU 2006241123 (A1) 2006-11-02 | - |
patents.relation.family | CA 2609656 (A1) 2006-11-02 | - |
patents.relation.family | CN 101267831 (A) 2008-09-17 | - |
patents.relation.family | DK 1879606 (T3) 2013-09-23 | - |
patents.relation.family | EP 1879606 (A1) 2008-01-23 | - |
patents.relation.family | EP 2283851 (A2) 2011-02-16 | - |
patents.relation.family | ES 2427565 (T3) 2013-10-31 | - |
patents.relation.family | HK 1112847 (A1) 2014-03-14 | - |
patents.relation.family | J P5204646 (B2) 2013-06-05 | - |
patents.relation.family | JP 2011168623 (A) 2011-09-01 | - |
patents.relation.family | J P5629241 (B2) 2014-11-19 | - |
patents.relation.family | JP 2014221830 (A) 2014-11-27 | - |
patents.relation.family | KR 20080007380 (A) 2008-01-18 | - |
patents.relation.family | KR 20100102750 (A) 2010-09-24 | - |
patents.relation.family | US 2009111734 (A1) 2009-04-30 | - |
patents.relation.family | WO 2006116524 (A1) 2006-11-02 | - |
patents.description.kind | A1 | - |
patents.type | Patent_granted | - |